Larvol Delta - A-Study-to-Evaluate-the-Safety-Tolerability-Pharmacokinetics-and-Preliminary-Efficacy-of-BMS986489-in-Chinese-Participants-With-RelapsedRefractory-Small-Cell-Lung-Cancer

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

atigotatug/nivolumab (BMS-986489) - BMS

http://clinicaltrials.gov/ct2/show/NCT06799286

Sep 24, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next